Finzati - Logo
SHC logo

Sotera Health Company

SHC • Medical - Diagnostics & Research
$17.88
▼ -0.05 (-0.28%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$5.08B
Growth
4.4%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Stable or improving margins · 6.7%Positive revenue growth · 5.3%Positive free cash flow · 0.53Consistent free cash flow · 4/5Healthy liquidity · 2.46
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$17.88
Change-0.28%
Shares Out287.92M
Market Cap$5.08B
Enterprise Value$4.72B
52W Range10.79 - 19.85
Beta1.80
P/E31.07
P/S4.18
P/B7.63
P/FCF74.03
EV/Sales3.88

Investment DNA

How strong this company looks for long-term investors

58
out of 100
Business Quality
Margins, moat, returns
69/100
Financial Strength
Debt, cash, stability
59/100
Growth Potential
Revenue and expansion
46/100
Price Attractiveness
Cheap or expensive today
41/100
Why this score▼
Stable or improving margins · 6.7%Positive revenue growth · 5.3%Positive free cash flow · 0.53Consistent free cash flow · 4/5Healthy liquidity · 2.46Expensive earnings multiple · 64.26

Analyst view

Analyst sentiment and price target

SHC
Analyst sentiment
Based on 12 analyst votes · 2026-10-20
92/100
Bullish
Bullish
11
Hold
0
Bearish
1
Price Target
2026-08-07
Low
$18.00
Mean
$19.00
Median
$19.00
High
$20.00

Company Overview

IPO: 11/20/2020
Industry: Medical - Diagnostics & Research
P/B i: 7.63
Debt / Equity i: 3.75
Operating Margin: 33.75%
Net Margin: 6.70%
ROE i: -
ROIC: -

Financial Health

Score12 / 20
Debt / Equity: 3.75
Current Ratio: 2.46
Quick Ratio: 2.24
Status: Good

Warnings

  • High debt level

Insider Transactions

Recent executive and insider activity

⚠ 2 high-volume insider sells detected
SHADER ALTON
Transaction: 05/26/2026
OTHER
Change
0
Price
Not reported
Filing
05/27/2026
Type
OTHER
SHADER ALTON
Transaction: 05/26/2026
BUY
Change
+101,817
Price
Not reported
Filing
05/27/2026
Type
BUY
SHADER ALTON
Transaction: 05/26/2026
BUY
Change
+375,939
Price
Not reported
Filing
05/27/2026
Type
BUY